Newsletter | April 4, 2024

04.04.24 -- 2024 LIMS Trends

Welcome to the redesigned Bioprocess Online newsletter! In addition to having a new look, the newsletter will now be delivered daily, and each issue will focus on a specific topic or topics. Visit your profile page to update your topic preferences and receive only the newsletter(s) of interest to you.

FOCUS ON ANALYTICS & QUALITY

2024 LIMS Trends

The laboratory information management system (LIMS) landscape in 2024 is a dynamic one, driven by accelerating advancements in technology and evolving industry needs. This article shares the four key trends.

Quality By Design And Affinity Chromatography

As more sophisticated protein structures are utilized in complex biologics development, how do we optimize affinity chromatography to ensure higher yields for more efficient biomanufacturing at scale?

Advanced Characterization Of ADCs And Antibody-Fusion Proteins

Learn about advanced characterization techniques to assess antibody-drug conjugates (ADCs) and antibody-fusion proteins.

Top 3 Megatrends In OT Cybersecurity

Explore the megatrends that are shaping the future of operational technology (OT) cybersecurity, and the strategic measures organizations can take to protect themselves against threats.

EMPQ And Validation Support Services

A growing pharmaceutical/biotech company hired a global consulting firm for a project that required EMPQ services for qualification activities on a newly completed aseptic processing suite.

DataOps For Manufacturing: A 4-Stage Maturity Model

Explore a maturity model that was created to help you better understand where you are on your DataOps journey and where you need to go to achieve the results you expect.

ANALYTICS & QUALITY SOLUTIONS

GxP Cloud Software Service - IDBS UK HQ

Liquid Handling Software That Ensures Accuracy and Repeatability - Advanced Instruments, Inc.

FOCUS ON REGULATORY

Understanding And Navigating Diverse Regulatory Environments

Drug developers aspire to treat patients globally, but navigating diverse regulatory structures around the world gets tricky. These consultants offer a primer on the regulatory bodies of the world.

Response To FDA Black Box Warning

The FDA has launched an investigation into the risk of T-cell malignancies following CAR-T cell immunotherapies. Review the key points of this announcement concerning the CGT research community.

ICH Q14 101: Applying AQbD To CMC For Regulatory Success

ICH Q14 provides comprehensive guidance on analytical procedure development, offering an invaluable framework for ensuring the development of regulatorily compliant analytical procedures.

SPONSOR

U.S. Biopharma Workforce Partnership Conference: April 17 and 18

Registration is open for a novel talent acquisition partnership conference this April orchestrated by the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The two-day conference in Boston brings together the industry with a myriad of biopharma-savvy universities, community colleges, and non-profits. The conference will be of keen interest to technical hiring managers, recruiters, and HR professionals.

Connect With Bioprocess Online: